Recent screens of a 2000-compound library using fibroblast cells from PD patients carrying parkin mutations have identified 15 compounds that can rescue mitochondrial dysfunction phenotypes of parkin-mutant patient cells [89]. This evidence concerns the gene PRKN and Parkinson disease.